Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-27 09:57:26 - browse：8527

STAT@ASCO 2024 — Chris Boshoff, far right, speaking at a panel with, from left, Matthew Herper of STAT, Ken Keller, Levi Garraway, and Susan Galbraith. Megan Bearder Photography

CHICAGO — The ways clinicians can treat cancers effectively are expanding, partly because technologies today are making old ideas possible, said a panel of oncology industry leaders at STAT@ASCO, STAT’s event here at the annual American Society of Clinical Oncology meeting.

“We’re seeing this expansion in modalities. We have more types of modalities that have arrived or arriving that allow us to exploit targets we’ve known about more than ever before. It’s very exciting,” said Levi Garraway, the chief medical officer of Genentech, at the event. “Things we’ve known about for a long time can be drugged for the first time or in a new, different way.”

That’s led to a surge of new medicines ranging from small molecules to cell therapies, with the potential uses of these treatments expanding into earlier lines of therapy and more cancer types each year. One example the panel singled out is the drug Enhertu, which recently received a tumor-agnostic approval from the Food and Drug Administration.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： What is STAT's opinion section for?

knowledge

WSS

Carbon Health diabetes program, a test of data

Study suggests Covid rebound is far more common with Paxlovid than without

Experimental asthma app from Apple and Anthem shows promise

Ventyx halts psoriasis drug development after lackluster trial results

Explaining an after

Cancer diagnosis changes perspective doctor, former hospital CEO

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

leisure time

Malaria cases in Florida and Texas: Here’s what you need to know

Ohio still needs to do more to protect the right to abortion

Medicare proposal to cover medical devices draws a mixed reaction

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Bright Health sells Medicare Advantage business to Molina

Carbon Health diabetes program, a test of data

In Memoriam: Notable people who died in 2023

FDA reorg will put new emphasis on investigations, sources say

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Travis Kelce and the trap of celebrity vaccine endorsements

leisure time

Life sciences investors close nearly $6 billion in new funds

Bill would allow buprenorphine prescription for addiction via telehealth

Carbon Health diabetes program, a test of data

After decades in use, heart stents finally beat placebo

Type 2 diabetes prevention programs work at large scale: study

UnitedHealth sued over use of algorithm in Medicare Advantage plans

knowledge

explore

explore

leisure time